Statins decrease the risk of decompensation in HBV ‐ and HCV‐related cirrhosis: A population‐based study

Conclusions: Statin use decreases the decompensation rate in both HBV‐ and HCV‐related cirrhosis. Of borderline significance is a decreased decompensation rate in alcohol‐related cirrhosis. This article is protected by copyright. All rights reserved.

Source: Hepatology - March 19, 2017 Category: Internal Medicine Authors: Fu ‐Ming Chang, Yen‐Po Wang, Hui‐Chu Lang, Chia‐Fen Tsai, Ming‐Chih Hou, Fa‐Yauh Lee, Ching‐Liang Lu Tags: Liver Failure, Cirrhosis and Portal Hypertension Source Type: research